中国科学院生物与化学交叉研究中心

设为首页 |中文版

研究团队

您的位置: 首页 > 研究团队 > 朱继东课题组 > 发表文章
发表文章

1、 Guangya Zhu , Jingjing Xie,Zhenzhen Fu , Mingliang Wang, Qichen Zhang, Hao He, Zijun Chen, Xin Guo, Jidong Zhu;Pharmacological inhibition of SRC-1 phase separation suppresses YAP oncogenic transcription activity;Cell Research,1748-7838;https://doi.org/10.1038/s41422-021-00504-x


2、Guangya Zhu,1,2,11 Jingjing Xie,1,2,11 Wenna Kong,1,2,11 Jingfei Xie,1,2,11 Yichen Li,3 Lin Du,4 Qiangang Zheng,4 Lin Sun,1 Mingfeng Guan,1,2 Huan Li,1,2 Tianxin Zhu,1,2 Hao He,1,2 Zhenying Liu,1,2 Xi Xia,1 Chen Kan,5 Youqi Tao,3 Hong C. Shen,6 Dan Li,3 Siying Wang,5 Yongguo Yu,7 Zhi-Hong Yu,8 Zhong-Yin Zhang,8,10 Cong Liu,1,* and Jidong Zhu1,9,12,*Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation;Cell 183, 1–13, October 15, 2020 Elsevier Inc.


3、Hengyi Cao,Guangya Zhu,Lin Sun,Ge Chen,Xinxin Ma,Xiao Luo,Jidong Zhu ;(2019)Discovery of new small molecule inhibitors targeting isocitrate dehydrogenase 1 (IDH1) with blood-brain barrier penetration; European Journal of Medicinal Chemistry, 183,111694;


4、Ge Chen, Chunyi Niu, Jianhua Yi, Lin Sun, Hengyi Cao , Yanjia Fang, Taijie Jin, Ying Li, Chunli Lou, Jingwu Kang,Wanguo Wei*, Jidong Zhu;(2019)Novel Triapine Derivative Induces Copper-Dependent Cell Death in Hematopoietic Cancers;J. Med. Chem, 62, 3107−3121


5、Li H, Fang Y, Niu C, Cao H, Mi T, Zhu H, Yuan J, Zhu J. Inhibition of cIAP1 as a strategy for targeting c-MYC-driven oncogenic activity. Proc Natl Acad Sci U S A. doi:10.1073/pnas.1807711115. 2018 Sep 4 .


6、Mingliang Wang  , Yanjia Fang , Shoulai Gu  , Fangfang Chen  , Zhengjiang Zhu  , Xun Sun , Jidong Zhu ,Discovery of novel 1,2,3,4-tetrahydrobenzo[4,5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors,European Journal of Medicinal Chemistry 132 (2017) 157e172.


7、Jingjing Xie, Xiaojia Si,Shoulai Gu, Mingliang Wang,  Jian Shen,Haoyan Li, Jian Shen, Dan Li, Yanjia Fang, Cong Liu, and Jidong Zhu , AllostericInhibitors of SHP2 with Therapeutic Potential for Cancer Treatment, J. Med.Chem. 2017, 60, 10205−10219.


8、Xuesong Liu, Linqian Yu, MupengLuo, Jidong Zhu,  and Wanguo Wei ,Radical-Induced Metal-Free Alkynylation of Aldehydes by Direct CH Activation,Chem. Eur. J. 2015, 21, 1–6.


9、Mingliang Wang,  Xixi Liu, Lu Zhou, Jidong Zhu and Xun Sun,Fluorination of 2-substituted benzo[b]furans with Selectfluor, DOI:10.1039/c4ob02691h, This journal is The Royal Society of Chemistry 2015.


10、Fang Cao, Elizabeth C.Townsend, Hacer Karatas, Jing Xu, Li Li, Shirley Lee, Liu Liu, Yong Chen,PeterOuillette, Jidong Zhu, Jay L. Hess,  Peter Atadja,  Ming Lei,  Zhaohui S. Qin, Sami Malek,  Shaomeng Wang,  and Yali Dou, Targeting MLL1 H3K4Methyltransferase Activity in Mixed-Lineage Leukemia,Molecular Cell 53, 247–261, January 23, 2014 Elsevier Inc.


11、Li Wang, Ling Li, Hailong Zhang,Xiao Luo, Jingquan Dai, Shaolian Zhou, Justin Gu, Jidong Zhu, Peter Atadja,Chris Lu, En Li, Kehao Zhao, Structure of human SMYD2 protein reveals the basisof p53 tumor suppressor methylation. J. Biol. Chem. 2011, 286(44), 38725-38737.


12、Jidong Zhu, John Blenis, Junying Yuan, Activation of PI3K/AKT and MAPKpathways regulates Myc mediated transcription by phosphorylating and promotingthe degradation of Mad1. Proc. Natl. Acad. Sci. USA 2008, 105 (18), 6584-6589.


13、Lei Xu*, Jidong Zhu*, Xiaofang Hu, Hong Zhu, Hyoung Tae Kim, Joshua LaBaer,Alfred Goldberg, and Junying Yuan, c-IAP1 cooperates with Myc by acting as aubiquitin ligase for Mad1. Mol. Cell 2007, 28 (5), 914-922. *: Co-firstauthors.


14、Biao Lu, XiaoAn Xie, Jidong Zhu, Dawei Ma, Sodium Amalgam, a useful reducingreagent for formation of amines from azides bearing a variety of functionalgroups. Chinese J. Chem. 2005, 23(12), 1637-1640.


15、Jidong Zhu, Dawei Ma, Total synthesis of Microsclerodermin E. Angew. Chem.Int. Ed. Engl. 2003, 42 (43), 5348-5351.

中国科学院生物与化学交叉研究中心 版权所有 电话:021-68582285/68582282
地址:上海市浦东张江高科技园区海科路100号 沪ICP备05005485号-3